Your browser doesn't support javascript.
loading
Effectiveness of infliximab biosimilars in the treatment of moderate to severe chronic plaque psoriasis: experience of real-world data from the register of the program "Treatment of moderate and severe forms of plaque psoriasis (B.47)" of the National Health Fund in Poland.
Owczarek, Witold; Walecka, Irena; Nowakowska, Agnieszka; Ciechanowicz, Piotr; Reich, Adam; Lesiak, Aleksandra; Borkowska, Ewa; Sliwczyñski, Andrzej; Narbutt, Joanna.
Afiliación
  • Owczarek W; Department of Dermatology, Military Institute of Medicine, Warsaw, Poland.
  • Walecka I; Department of Dermatology, Centre of Postgraduate Medical Education, Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw, Poland.
  • Nowakowska A; Department of Dermatology, Military Institute of Medicine, Warsaw, Poland.
  • Ciechanowicz P; Department of Dermatology, Centre of Postgraduate Medical Education, Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw, Poland.
  • Reich A; Department of Dermatology, University of Rzeszow, Rzeszow, Poland.
  • Lesiak A; Department of Dermatology, Paediatric and Oncological Dermatology, Medical University of Lodz, Lodz, Poland.
  • Borkowska E; Department of Medicine, Medical University of Warsaw, Warsaw, Poland.
  • Sliwczyñski A; University of Humanities and Economics in Lodz, Satellite Campus, Warsaw, Poland.
  • Narbutt J; Department of Dermatology, Paediatric and Oncological Dermatology, Medical University of Lodz, Lodz, Poland.
Postepy Dermatol Alergol ; 39(4): 723-728, 2022 Aug.
Article en En | MEDLINE | ID: mdl-36090728

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Evaluation_studies Idioma: En Revista: Postepy Dermatol Alergol Año: 2022 Tipo del documento: Article País de afiliación: Polonia

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Evaluation_studies Idioma: En Revista: Postepy Dermatol Alergol Año: 2022 Tipo del documento: Article País de afiliación: Polonia